NA- NA

https://updates.chemo.org.uk/CDF_Forms/PEMB32.html

🚨 Moved into routine commissioning - section...

Obecabtagene autoleucel- Obecabtagene autoleucel (obecel) CAR-T cells for treating relapsed/refractory Philadelphia negative or positive B cell precurso...

https://updates.chemo.org.uk/CDF_Forms/OBE01a.html

🚨 Recommended for routine commissioning, rec...

Dostarlimab in combination with platinum-c...- For the 1st line treatment of mismatch repair proficient (pMMR) or microsatellite stable endometrial carcinoma in adult patient...

https://updates.chemo.org.uk/CDF_Forms/DOS3.html

🚨 Recommended for routine commissioning, rec...

Durvalumab in combination with tremelimumab- For first-line systemic treatment of adult patients with locally advanced or metastatic and/or unresectable hepatocellular carc...

https://updates.chemo.org.uk/CDF_Forms/DUR6.html

🚨 Moved into routine commissioning - section...

Talquetamab monotherapy- For treating relapsed or refractory multiple myeloma after 3 or more treatments

https://updates.chemo.org.uk/CDF_Forms/TALQ1.html

🚨 Recommended for routine commissioning, rec...

Darolutamide in combination with androgen ...- For the treatment of patients with newly diagnosed metastatic hormone-sensitive prostate cancer who are unsuitable for treatmen...

https://updates.chemo.org.uk/CDF_Forms/DARO3.html

🚨 Date moving into routine commissioning upd...

Ribociclib in combination with an aromatas...- Ribociclib in combination with an aromatase inhibitor as adjuvant treatment for high risk hormone receptor-positive and HER2-ne...

https://updates.chemo.org.uk/CDF_Forms/RIB3.html

🚨 Moved into routine commissioning - section...

Sorafenib monotherapy- Treatment of Child-Pugh A locally advanced or metastatic hepatocellular carcinoma where the following criteria met:

https://updates.chemo.org.uk/CDF_Forms/SOR3.html

🚨 Treatment criteria (#4 and 8) updated

Pembrolizumab- Pembrolizumab monotherapy for treating unresectable or advanced malignant melanoma (form a): REGISTRATION OF START OF PEMBROLIZ...

https://updates.chemo.org.uk/CDF_Forms/PEMB9a.html

🚨 Treatment criteria (#4 and 10) updated